Morningstar

Becton Dickinson & Co BDX

Stock XNYS Rating as of Oct 1, 2026

News

BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy

PR Newswire Sep 29, 2026, 1:00:00 PM
Arthur Hu to Join BD as Chief Information and Digital Officer

PR Newswire Sep 21, 2026, 8:30:00 PM
BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview

PR Newswire Sep 14, 2026, 10:50:00 AM
BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation

PR Newswire Aug 27, 2026, 10:50:00 AM
BD to Present at Wells Fargo 21st Annual Healthcare Conference

PR Newswire Aug 26, 2026, 8:15:00 PM
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire

PR Newswire Aug 17, 2026, 8:30:00 PM
BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

PR Newswire Aug 12, 2026, 10:50:00 AM
BD Reports Third Quarter Fiscal 2026 Financial Results

PR Newswire Aug 6, 2026, 10:30:00 AM
EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch

PR Newswire Jul 29, 2026, 10:54:00 AM
BD Board Declares Dividend

PR Newswire Jul 28, 2026, 8:15:00 PM
Mike Garrison to Retire from BD

PR Newswire Jul 22, 2026, 10:55:00 AM
BD to Announce Financial Results for its Third Quarter of Fiscal 2026

PR Newswire Jul 9, 2026, 8:15:00 PM
Becton Dickinson Resumes U.S. Shipments of ChloraPrep

Global News Select May 29, 2026, 1:36:00 PM
Waters Gets FDA Approval for At-Home HPV Self-Collection Kit

Global News Select Apr 8, 2026, 12:48:00 PM

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.